UFP Technologies, Inc. (UFPT) Financials

UFPT Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 674.7 million 235.8 million
Dec. 31, 2025 665.7 million 241.9 million
Sept. 30, 2025 652.8 million 248.9 million
June 30, 2025 634.7 million 249.2 million

UFPT Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 1.5 million 2.7 million
Dec. 31, 2025 13.0 million 2.4 million
Sept. 30, 2025 32.5 million 2.0 million
June 30, 2025 22.5 million 2.3 million

UFPT Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 17.5 million
Dec. 31, 2025 17.6 million
Sept. 30, 2025 16.4 million
June 30, 2025 17.2 million

UFPT Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 20.0 million 125.1 million 13.4 million
Dec. 31, 2025 20.3 million 123.0 million 19.0 million
Sept. 30, 2025 18.2 million 133.6 million 19.4 million
June 30, 2025 14.9 million 151.1 million 17.5 million

UFPT Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 7.8 million
Dec. 31, 2025 7.8 million
Sept. 30, 2025 7.8 million
June 30, 2025 7.8 million

UFPT Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.7 million - 21.0 million -
Dec. 31, 2025 3.9 million - 21.0 million -
Sept. 30, 2025 3.4 million - 19.1 million -
June 30, 2025 2.9 million - 18.7 million -

UFPT Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 154.2 million 109.8 million
Dec. 31, 2025 148.9 million 106.9 million
Sept. 30, 2025 154.6 million 111.8 million
June 30, 2025 151.2 million 107.6 million

UFPT Revenue by Segment

Graph available only for paid members. Upgrade to see it.

UFPT

Price: $237.20

52 week price:
173.86
275.20

Payout Ratio Range:
0.00%
194.58%

Earnings Per Share: 8.79 USD

P/E Ratio: 25.25

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 22096

Ebitda: 3.9 million

Market Capitalization: 2.1 billion

Links: